Sort
48,018 grants matching “immunotherapy”
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$575,240Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Project 1: Targeting Metabolic Dependencies in PDAC
$575,225Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$575,119Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · NS
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$575,015Michael R Wilson · University Of California, San Francisco · R01 · FY2024 · NS
Testing the role of BATF as a pioneer transcription factor in effector T cells
$575,007William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2017 · AI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$574,981Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$574,981Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Clinical Cancer Cytogenetics
$574,913Diane C Arthur · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
PSMA-VRP vaccine for prostate cancer
$574,893William C Olson · Progenics Pharmaceuticals, Inc. · R44 · FY2008 · CA
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$574,829Emmanuel J Mignot · Stanford University · U01 · FY2025 · NS
Modified HER-2 Tumor Antigens for Vaccination in Cancer
$574,787Mark J. Mamula · L2 Diagnostics, Llc · R42 · FY2007 · CA
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS
$574,782University Of Pittsburgh At Pittsburgh · R01 · FY2000 · AI
Mechanisms of Murine Turmor Eradication by Immunotherapy
$574,748Philip D Greenberg · University Of Washington · R01 · FY2017 · CA
Engineered Nano-formulations for STING Activation
$574,732James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2022 · DE
Finding the optimal balance of immunotherapy efficacy and toxicity.
$574,731David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2022 · AI
Personalized, antigen-directed immunotherapy delivered to lymph nodes
$574,500Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Targeting Amino Acid Metabolism in Glioblastoma
$574,427Jeremy N Rich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · NS
3D Models of Immunotherapy
$574,412David J Mooney · Harvard University · U01 · FY2017 · CA
Planning and Evaluation
$574,270Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2021 · CA
Planning and Evaluation
$574,270Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2023 · CA
Planning and Evaluation
$574,270Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2022 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$574,234Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$574,170Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2017 · CA
Mechanoregulation of cytotoxic lymphocyte function
$574,138Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2022 · AI
Uterine NK Cells in Primate Pregnancy
$574,102Thaddeus G Golos · University Of Wisconsin-Madison · R01 · FY2009 · HD